At the Federal Bar Association’s annual qui tam conference in Washington, D.C. on Feb. 20, 2025, the Deputy Assistant Attorney General for the Department of Justice’s (DOJ) Commercial Litigation Branch, Michael Granston, said...more
2/24/2025
/ Compliance ,
Department of Justice (DOJ) ,
Enforcement Actions ,
False Claims Act (FCA) ,
Fraud ,
Government Agencies ,
Healthcare ,
Healthcare Fraud ,
International Trade ,
Regulatory Agenda ,
Trump Administration
Compared with other issues, healthcare enforcement during President-elect Donald Trump’s upcoming second term has received little attention. When he takes office again on January 20, should industry actors like pharmaceutical...more
1/6/2025
/ Anti-Kickback Statute ,
Bad Actors ,
Centers for Medicare & Medicaid Services (CMS) ,
Clinical Laboratories ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Enforcement ,
Enforcement Actions ,
False Claims Act (FCA) ,
Healthcare ,
Healthcare Fraud ,
Hospitals ,
Pharmaceutical Industry ,
Presidential Nominations ,
Trump Administration
Damian Williams, the U.S. Attorney for the Southern District of New York, announced an expansion of his office’s priorities for 2024, adding fights against the fentanyl epidemic and public corruption to its previously stated...more